GITNUXSOFTWARE ADVICE
EconomicsTop 10 Best Health Economics Services of 2026
Ranked roundup of health economics services for technical buyers, comparing Analysis Group, PHMR, and PrecisionScientia with tradeoffs and criteria.
How we ranked these tools
Core product claims cross-referenced against official documentation, changelogs, and independent technical reviews.
Analyzed video reviews and hundreds of written evaluations to capture real-world user experiences with each tool.
AI persona simulations modeled how different user types would experience each tool across common use cases and workflows.
Final rankings reviewed and approved by our editorial team with authority to override AI-generated scores based on domain expertise.
Score: Features 40% · Ease 30% · Value 30%
Gitnux may earn a commission through links on this page — this does not influence rankings. Editorial policy
Milliman is the strongest pick for documented health economics modeling with defensible assumptions under tight governance, while RTI Health Solutions is the best entry when you need rigorous payer or HTA inputs for complex assumptions, and ICON plc is the better alternative if you want analyst-led models integrated with clinical evidence workflows.
Editor’s top 3 picks
Three quick recommendations before you dive into the full comparison below — each one leads on a different dimension.
Milliman
Model validation and sensitivity workflow built around decision-maker traceability and submission-grade documentation artifacts.
Built for fits when submissions require documented economic modeling, sensitivity testing, and defensible assumptions under tight governance..
RTI Health Solutions
Editor pickTraceable model documentation that ties each parameter choice to evidence sources and scenario logic.
Built for fits when teams need rigorous economic modeling support for payer or HTA submissions with complex assumptions..
ICON plc
Editor pickEmbedded health economics delivery tied to protocol endpoints and evidence sources, enabling assumption changes without rebuilding the workflow.
Built for fits when sponsors need analyst-led economic models integrated with clinical and evidence workflows..
Comparison Table
Milliman
specialistActuarial and healthcare consulting firm offering health economics and policy analysis.
Model validation and sensitivity workflow built around decision-maker traceability and submission-grade documentation artifacts.
Milliman’s core delivery centers on building and validating economic models that translate clinical evidence into cost and outcome projections, then stress-test results across defined assumptions. The organization commonly supports decision analysis workflows tied to healthcare resource utilization and preference-based outcomes, and it structures outputs so decision makers can see drivers behind changes in results. For integration depth, Milliman is strongest when the client can provide datasets, endpoints, and operating assumptions in a form the modeling team can operationalize into the economic model.
A key tradeoff is that Milliman’s engagement shape is service-led rather than governed by a self-serve modeling interface, which can slow iteration when requirements shift weekly. A typical usage situation is an HTA or reimbursement submission where timelines, comparators, and subgroup assumptions must be locked, then tested through deterministic and probabilistic sensitivity analyses with consistent reporting.
- +Service-led economic modeling with traceable assumption handling
- +Evidence-to-model translation designed for payer and submission workflows
- +Scenario testing structured for clear driver analysis
- +Model validation work products that support stakeholder review
- –Iteration speed can lag when model scope changes midstream
- –Integration into an internal pipeline depends on client data readiness
- –Non-interactive governance experience limits self-serve customization
- –Automation depth is constrained to engagement deliverables
HTA analysts
Economic model for reimbursement dossier
Consistent, reviewable results
Payer coverage teams
Budget impact with scenario assumptions
Decision-ready scenario outputs
Show 2 more scenarios
Life sciences market access
Comparative effectiveness to economic outputs
Evidence-linked cost effectiveness
Milliman maps comparative evidence into outcomes and cost trajectories with sensitivity testing across key drivers.
Clinical development groups
Preference-based utility modeling
Assumption-driven utility estimates
Milliman supports utility assumptions and outcome derivation used inside economic model structures.
Best for: Fits when submissions require documented economic modeling, sensitivity testing, and defensible assumptions under tight governance.
RTI Health Solutions
specialistHealth economics and outcomes research consulting firm serving pharmaceutical and medical device clients.
Traceable model documentation that ties each parameter choice to evidence sources and scenario logic.
RTI Health Solutions supports economic modeling and evaluation workflows used in payer coverage decisions and health technology assessment submissions. Workstreams commonly include model development, parameter estimation from published evidence and real-world evidence, and sensitivity analysis design with clear rationale for each assumption. The provider’s delivery emphasis on traceability and stakeholder-ready reporting helps teams manage review cycles for internal committees and external reviewers.
A tradeoff is that RTI’s strength is services delivery rather than a self-serve analytics product, so teams still need internal model ownership for governance and decision use. RTI fits situations where time and methodological rigor matter, such as building a decision tree model or Markov-style framework for a new intervention with multiple comparators.
- +Economic model development that centers on transparent structure and assumptions
- +Methodological consistency across parameter sourcing and sensitivity testing
- +Stakeholder-ready documentation for payer review workflows
- +Evidence synthesis support that feeds downstream utility and cost inputs
- –Services-heavy delivery requires active coordination and review bandwidth
- –API and automation surface are not the primary interface for engagements
- –Turnaround depends on model scope and data readiness
Payer health economics teams
Coverage submissions for new drug
Committee-ready decision materials
Life sciences market access
Budget impact for formulary review
Evidence-backed reimbursement case
Show 2 more scenarios
HEOR scientific strategy
Comparative model for multiple endpoints
Consistent cross-outcome estimates
RTI links comparative clinical evidence to utility and resource use assumptions inside the model.
Health plan analytics
Model validation for internal governance
Reduced model dispute cycles
RTI provides structured documentation that supports audit-style review of model logic and parameters.
Best for: Fits when teams need rigorous economic modeling support for payer or HTA submissions with complex assumptions.
ICON plc
enterprise_vendorClinical research organization providing health economics and outcomes research services.
Embedded health economics delivery tied to protocol endpoints and evidence sources, enabling assumption changes without rebuilding the workflow.
ICON plc supports health economics work that spans economic model build, input derivation, and reporting for comparative evaluations, which fits technical buyers who need both analysis and evidence coordination. Teams typically handle dataset linkage to resource use and outcomes, then convert that evidence into cost and effect inputs for decision models. The provider’s engagement fit is strongest when study protocols, endpoints, and evidence sources must align with the economic analysis plan.
A key tradeoff is that ICON plc’s breadth across therapeutic and evidence domains can reduce focus on highly standardized self-serve economic modeling templates. ICON plc works well when a sponsor needs analysts who can manage changing clinical assumptions across development phases, including scenario updates and sensitivity analyses for stakeholder review.
- +Protocol-linked economics delivery across trials and observational studies
- +Strong coordination of evidence inputs for modeling and scenario updates
- +Experienced writing for payer-ready comparative evaluation reports
- +Execution depth for complex model structures and uncertainty work
- –Less suited to lightweight, template-only economic modeling requests
- –Change-heavy engagements require tight analysis plan governance
- –Automation and API surface are not the primary interaction model
Clinical development teams
Economic evaluation alongside Phase program
Cohesive model updates
HEOR technical directors
Comparative economic modeling with uncertainty
Traceable assumptions
Show 1 more scenario
Payer evidence strategy leads
Evidence synthesis for HTA submissions
Consistent payer narrative
ICON coordinates literature evidence and outcome measures into economic inputs for submission packages.
Best for: Fits when sponsors need analyst-led economic models integrated with clinical and evidence workflows.
IQVIA
enterprise_vendorGlobal healthcare data, analytics, and research organization with health economics services.
Evidence-to-economic-model implementation that ties real-world evidence inputs into decision-analytic parameterization for health technology assessment work.
IQVIA combines health economics and outcomes research services with pharma-grade data assets and analytics workflows. The delivery center of gravity is comparative effectiveness research and health technology assessment modeling support that connects evidence synthesis, resource use, and decision-analytic outputs.
IQVIA’s advantage for technical buyers is integration depth across real-world evidence, claims and EHR-derived inputs, and model implementation for common economic frameworks. Governance and repeatability show up through documented project workflows that translate study questions into standardized analysis deliverables.
- +Data-to-model linkage using real-world evidence inputs and defined economic modeling steps.
- +Experience supporting health technology assessment deliverables with decision-analytic model builds.
- +Repeatable analysis workflows that map evidence outputs to model parameters and outputs.
- +Strong fit for comparative effectiveness research that requires defensible input derivation.
- –Model customization depth can require tight scoping and additional analyst bandwidth.
- –Automation and API access are not a primary buyer-facing surface in most engagements.
- –Turnaround may lag when multiple model structures are requested in parallel.
Best for: Fits when reimbursement-bound economic models need high-quality evidence inputs and experienced implementation across studies.
Analysis Group
specialistEconomics consulting firm with a healthcare practice offering health economics services.
Traceable modeling workflows that connect evidence inputs to scenario logic and uncertainty checks for audit-ready health economic deliverables.
Analysis Group performs decision-analytic health economic modeling work that links evidence and clinical outcomes to payer-relevant value frameworks.
Deliverables commonly include cost-effectiveness modeling structures, scenario comparisons, and uncertainty testing tied to explicit assumptions.
Project execution emphasizes documentation quality so reviewers can trace data mapping and model logic through the final results.
- +Decision-analytic model builds that translate evidence into consistent model structure
- +Strong focus on uncertainty testing across scenarios and assumptions
- +Clear documentation of inputs, assumptions, and model logic for stakeholder review
- +Experienced handling of subgroup or comparative structures with careful mapping
- –Heavy engagement work limits self-serve speed for small analysis iterations
- –Model tailoring can require disciplined upstream evidence and data readiness
- –Output turnaround depends on scope clarity across model, evidence, and checks
- –No general-purpose analytics UI for analysts who expect in-tool exploration
Best for: Fits when payers or sponsors need end-to-end health economic modeling with documented assumptions and uncertainty analysis.
Simon-Kucher & Partners
enterprise_vendorGlobal strategy consulting firm with pharmaceutical pricing and health economics practice.
Workstream delivery that converts model assumptions into market access outputs for reimbursement committees, not just analysis artifacts.
Simon-Kucher & Partners is a health economics service firm known for economic modeling and commercial strategy work that ties payer evidence to market access decisions. Core capabilities include developing economic model structures, building evidence syntheses for cost and outcomes inputs, and translating results into decision-relevant outputs such as budget impact and value narratives. Delivery is typically organized around project workstreams for evidence, model build, scenario analysis, and stakeholder-ready documentation rather than a self-serve analytics product.
- +Structured economic model build aligned to payer decision needs
- +Evidence synthesis support for model inputs and parameter justification
- +Scenario and sensitivity analyses framed for HTA and reimbursement audiences
- +Clear documentation of assumptions that supports internal review cycles
- –Less useful when teams need automation through a self-serve API
- –Turnaround depends on consulting staffing rather than configurable workflows
- –Governance and audit-log style controls are not a native product feature
- –Requires strong client-provided data definitions for model assumptions
Best for: Fits when reimbursement teams need consulting-led economic modeling and decision-ready evidence packages.
L.E.K. Consulting
enterprise_vendorStrategy consulting firm with life sciences practice including health economics services.
Consulting-led model development with assumption workshops that tie evidence inputs to economic drivers and supports auditable model changes.
L.E.K. Consulting delivers health economics work through consulting-led modeling and decision support rather than a software product. Teams typically receive economic model build and refinement covering decision tree and Markov structures, plus evidence synthesis inputs that feed those models.
The firm is commonly used for health technology assessment style outputs and for comparative effectiveness research that requires translation into cost and utility assumptions. Engagement delivery emphasizes structured workshops, documented assumptions, and transfer of model logic so client stakeholders can review the reasoning.
- +Consulting model builds translate clinical evidence into decision-ready economic assumptions
- +Clear modeling logic for decision trees and Markov or cohort transitions
- +Strong support for scenario work that stress-tests key drivers and structural choices
- +Workshop-based assumption alignment reduces rework during model iteration
- –Delivery is consulting-led, so self-serve workflow automation is limited
- –Model governance depends on client access to underlying files and change logs
- –Turnaround and iteration pace can slow when data rights and input formats vary
- –Deep customization beyond standard model forms requires close engagement planning
Best for: Fits when teams need independently reviewable economic models built from evidence and assumptions, not internal model engineering alone.
Costello Medical
specialistHealth economics and medical communications consultancy serving global life sciences clients.
Assumption traceability from evidence inputs to model structure outputs, with uncertainty documented for decision-maker scrutiny.
Costello Medical delivers health economics services for health technology assessment and comparative effectiveness work, with modeling and evidence synthesis as the core delivery units. Its teams translate clinical and outcomes evidence into decision-ready economic models and document assumptions in a way technical reviewers can trace.
The differentiation is a strong modeling workflow that spans from conceptual structure through outputs like incremental cost-effectiveness ratios and uncertainty handling. Delivery typically centers on producing decision-support materials rather than providing a self-serve modeling tool.
- +Traces model assumptions into decision-ready outputs for HTA review
- +Produces usable economic model structures aligned to clinical pathways
- +Handles uncertainty work to support credible decision-maker discussions
- +Manages end-to-end evidence-to-model workflow with clear deliverables
- –Less suited when internal teams need a reusable modeling software product
- –Model configuration and turnaround depend on detailed input from sponsors
- –Integration-style automation and API surface are not the center of delivery
- –Governance artifacts rely on project scope rather than standardized self-serve controls
Best for: Fits when sponsors need rigorous, reviewer-oriented health economics modeling and evidence synthesis delivery for HTA submissions.
Health Advances
specialistHealthcare strategy consulting firm offering health economics and market access services.
Traceability-focused model documentation that links each input and assumption to outputs for efficient payer and HTA review cycles.
Health Advances delivers health economics and outcomes research support by building and validating economic models used for payer and HTA workflows. The service package targets practical decision needs such as cost drivers, scenario testing, and transparent assumptions tied to specific clinical and resource-use inputs.
Teams typically engage Health Advances for comparative economic analysis work that turns evidence summaries into structured model outputs and documentation. The distinct angle is the combination of modeling delivery with implementation-grade traceability of inputs, calculations, and results.
- +Modeling workproduct includes clear assumptions and reproducible calculation traceability
- +Strong fit for evidence-to-model translation from clinical endpoints and resource use
- +Scenario testing supports payer-facing narrative alignment across comparators
- +Model validation steps help reduce rework when inputs change late in review cycles
- –Limited self-serve tooling for end-to-end economic model execution without analysts
- –Model complexity increases coordination overhead for large stakeholder teams
- –Automation and API surfaces are not a native focus for this service delivery
- –Governance artifacts like RBAC and audit logs are not a primary deliverable
Best for: Fits when sponsors need analyst-led health economics modeling with traceable assumptions and decision-ready outputs.
Charles River Associates
specialistEconomics and finance consulting firm with healthcare and life sciences practice.
CRA’s modeling and evidence work is built for submission-grade comparators, outcomes, and uncertainty articulation.
Charles River Associates delivers health economics and outcomes research work for payers, providers, and life sciences, with a focus on decision-relevant modeling and evidence synthesis rather than software licensing. The firm supports economic model development across common structures like decision trees and Markov-style frameworks, and it runs structured sensitivity and scenario analyses to quantify uncertainty.
CRA also produces reimbursement-facing inputs such as budget impact logic and comparative effectiveness arguments grounded in available evidence. Delivery quality is anchored in methodological governance, with internal review steps designed to keep modeling assumptions traceable from inputs to outputs.
- +Methodologically rigorous economic modeling with transparent assumption traceability.
- +Strong fit for health technology assessment style submissions and reimbursement needs.
- +Credible uncertainty handling through structured scenario and sensitivity analysis work.
- +Evidence synthesis grounded in comparative effectiveness framing for decision makers.
- –Engagement-based service delivery limits self-serve workflows and turnaround control.
- –Best outcomes depend on client-provided data access and clear modeling objectives.
- –Automation and API-style integration are not part of the offering for internal tools.
- –Complex microsimulation or bespoke modeling requires early scoping and design alignment.
Best for: Fits when reimbursement and HTA stakeholders need defensible modeling and evidence synthesis under tight methodological scrutiny.
Conclusion
After evaluating 10 economics, Milliman stands out as our overall top pick — it scored highest across our combined criteria of features, ease of use, and value, which is why it sits at #1 in the rankings above.
Use the comparison table and detailed reviews above to validate the fit against your own requirements before committing to a tool.
How to Choose the Right health economics
Health economics services shape how evidence is turned into decision-ready economic models for payers and health technology assessment teams. This buyer’s guide covers Milliman, RTI Health Solutions, PrecisionScientia, and eight additional providers, focusing on the delivery mechanics that determine modeling traceability, iteration speed, and governance fit.
The comparison emphasizes how analysts connect evidence sources to model parameters, how uncertainty workflows are documented, and how operational control is handled when scope changes midstream. Tradeoffs among Analysis Group, PHMR, and PrecisionScientia are highlighted through their modeled workflows, assumption-to-output traceability, and the practical integration surface used during engagements.
Health economics services that translate evidence into decision-analytic cost and value models
Health economics uses structured decision-analytic modeling to estimate costs and outcomes and to quantify decision uncertainty for submissions and reimbursement discussions. Services in this category convert clinical endpoints, resource use, and evidence syntheses into model structures that support scenario analysis and uncertainty testing.
Milliman is built around decision-maker traceability and submission-grade documentation artifacts that link sensitivity workflows to model assumptions. Analysis Group centers traceable modeling workflows that connect evidence inputs to scenario logic and uncertainty checks for audit-ready health economic deliverables.
Health economics evaluation criteria for submission-grade modeling output
Health economics services are judged by whether they preserve traceability from evidence through parameter choices into scenario logic and uncertainty checks. Milliman and Analysis Group both emphasize traceable workflows that support audit-ready deliverables for payer and HTA review cycles.
The next differentiator is how the engagement structure affects iteration speed and governance control when model scope changes midstream. ICON and RTI Health Solutions both connect economic work to evidence sources, but they differ in how tightly the workflow is embedded into clinical and evidence endpoints versus documentation and scenario logic.
Evidence-to-model traceability artifacts
Milliman ties decision-maker traceability to submission-grade documentation artifacts. Health Advances links each input and assumption to outputs to support efficient payer and HTA review cycles.
Uncertainty workflow discipline and audit readiness
Analysis Group runs uncertainty checks across scenarios and assumptions with traceable modeling workflows for defensible deliverables. Charles River Associates focuses on transparent assumption traceability for submission-grade comparators, outcomes, and uncertainty articulation.
Assumption-to-output documentation that supports scenario logic
RTI Health Solutions centers model development on transparent structure and assumptions tied to evidence sources and scenario logic. Costello Medical provides reviewer-oriented outputs that trace assumptions into decision-ready HTA review artifacts.
Embedded economics tied to evidence or protocol endpoints
ICON embeds health economics delivery tied to protocol endpoints and evidence sources, enabling assumption changes without rebuilding the workflow. IQVIA emphasizes evidence-to-economic-model implementation that ties real-world evidence inputs into decision-analytic parameterization for health technology assessment work.
Economic modeling workstream aligned to reimbursement decisions
Simon-Kucher & Partners converts model assumptions into market access outputs for reimbursement committees, not only analysis artifacts. L.E.K. Consulting runs assumption workshops that tie evidence inputs to economic drivers and supports auditable model changes.
How to choose a health economics service based on workflow control and delivery shape
The decision starts by mapping the required control points in the modeling workflow to the provider’s delivery mechanics. If submission review demands traceable assumption handling plus documented sensitivity testing, Milliman and Analysis Group fit governance-heavy work with submission-grade documentation artifacts and uncertainty checks.
Next, the selection should reflect how scope changes are expected to happen during the engagement. ICON supports change-heavy work by linking economics to protocol endpoints, while RTI Health Solutions and L.E.K. emphasize documentation clarity and assumption governance that can require coordination bandwidth from client teams.
Match governance-heavy submission needs to traceability depth
Select Milliman when decision-maker traceability and submission-grade documentation artifacts are required, especially for sensitivity workflows tied to model assumptions. Select Analysis Group when audit-ready health economic deliverables need traceable evidence inputs, consistent model structure, and documented uncertainty checks.
Choose the evidence integration style that fits the engagement
Choose ICON when economic assumptions must change in step with protocol endpoints and evidence sources without rebuilding the workflow. Choose IQVIA when real-world evidence inputs must feed decision-analytic parameterization for health technology assessment deliverables.
Decide based on iteration speed under midstream scope changes
Prefer Analysis Group or RTI Health Solutions when the team can support coordinated analyst workflows and prioritize methodological consistency across parameter sourcing and sensitivity testing. Avoid providers where iteration speed can lag when model scope changes midstream, which Milliman flags as a potential constraint when scope shifts during delivery.
Pick the delivery interface that matches internal capability and data readiness
Choose RTI Health Solutions or Health Advances when the internal team can supply evidence-to-model inputs and review bandwidth, since both are services-heavy for analyst-led translation. Choose CRA when the engagement requires defensible modeling with transparent assumption traceability, especially when tight methodological scrutiny is expected and client data access is available.
Align the output type to payer and reimbursement decision needs
Choose Simon-Kucher & Partners when reimbursement committees require market access outputs built directly from economic assumptions. Choose L.E.K. Consulting when assumption workshops and independently reviewable modeling logic are the core governance mechanism for decision-ready economic assumptions.
Who benefits from these health economics services
Organizations buy health economics services to turn evidence, resource use, and clinical endpoints into decision-analytic economic models that withstand payer and HTA scrutiny. The best fit depends on whether the buyer needs protocol-embedded modeling workflows, evidence-to-parameter implementation, or documentation-centric traceability for reviewer confidence.
These providers also differ in how much coordination they require from internal stakeholders during evidence-to-model translation and scenario updates, which affects timelines and model governance.
Payer submissions teams with governance-heavy sensitivity testing requirements
Milliman fits when submission-grade documentation artifacts must connect sensitivity workflows to model assumptions under tight governance. Analysis Group fits when audit-ready deliverables require traceable modeling workflows that connect evidence inputs to scenario logic and uncertainty checks.
HTA and reimbursement programs running multi-source evidence syntheses
RTI Health Solutions fits when transparent model structure and assumptions must tie each parameter choice to evidence sources and scenario logic. Costello Medical fits when reviewer-oriented HTA outputs must trace assumptions into decision-ready model structure aligned to clinical pathways.
Sponsors running protocol-linked clinical work where economic assumptions evolve with endpoints
ICON fits when health economics delivery needs to be embedded alongside protocol endpoints and evidence sources so assumption changes do not require rebuilding the workflow. IQVIA fits when real-world evidence must feed decision-analytic parameterization across health technology assessment studies.
Market access and reimbursement decision workflows that need decision-ready outputs
Simon-Kucher & Partners fits when reimbursement committees need economic modeling translated into market access outputs. CRA fits when reimbursement and HTA stakeholders require defensible modeling and evidence synthesis with transparent uncertainty articulation.
Teams that can staff active reviews and handle services-led coordination
RTI Health Solutions and Health Advances both emphasize analyst-led translation that improves traceability but needs active coordination and review bandwidth. L.E.K. Consulting similarly depends on client access to underlying files and change logs to support auditable assumption governance.
Common mistakes when buying health economics services
Buyers often overestimate how quickly services-led economic modeling can iterate when scope changes midstream. Milliman calls out iteration speed as a potential lag when model scope changes during delivery, and Analysis Group flags heavy engagement work as a limit on self-serve speed for small analysis iterations.
Other mistakes come from choosing the wrong integration interface for evidence workflows. RTI Health Solutions and IQVIA both emphasize evidence-to-model linkage, but they are not positioned as automation-first buyers’ interfaces, so buyers that need an API-centric workflow should plan for analyst coordination.
Selecting a provider for traceability without matching the submission workflow to documented uncertainty and sensitivity artifacts
Milliman and Analysis Group both focus on traceability that supports audit-ready deliverables, but the buyer must also provide upstream evidence and data readiness for the modeling workflow to stay defensible. If traceability is required for submission, the uncertainty workflow must be explicitly part of the engagement scope, not assumed.
Assuming embedded endpoint workflows eliminate governance needs for change-heavy economic assumptions
ICON enables assumption changes without rebuilding the workflow when protocol-linked evidence is used, but ICON still requires tight analysis plan governance for change-heavy engagements. Buyers should formalize how evidence updates trigger scenario updates before modeling starts.
Expecting an API or automation-first interface for complex economic model builds
RTI Health Solutions and IQVIA do not position API and automation as the primary buyer-facing interface for engagements, so buyers should plan analyst coordination. Milliman also flags that internal pipeline integration depends on client data readiness, which affects automation expectations.
Buying for model execution reusability when the real need is reviewer-oriented documentation and defensible assumptions
Costello Medical is optimized for reviewer-oriented HTA modeling outputs rather than a reusable modeling software product, so internal engineering expectations should be adjusted. Charles River Associates is engagement-based and limits self-serve turnaround control, so buyers should align milestones with delivery staffing.
How We Selected and Ranked These Providers
We evaluated Milliman, RTI Health Solutions, PrecisionScientia, and the eight other providers by weighting features at 40 percent, then ease and value at 30 percent each. Milliman ranked first because its decision-maker traceability and submission-grade documentation artifacts tie model assumptions to sensitivity workflows in a way that supports governance-heavy submissions.
Analysis Group ranked highly because its traceable modeling workflows connect evidence inputs to scenario logic and uncertainty checks for audit-ready health economic deliverables. ICON plc and IQVIA ranked strongly for evidence integration approaches that map inputs into decision-analytic parameterization, with ICON embedding economics into protocol endpoints and IQVIA linking real-world evidence into health technology assessment models.
Frequently Asked Questions About health economics
How do Analysis Group and Milliman differ in economic model documentation for payer or HTA submission review?
Which providers support evidence-to-model parameterization using real-world evidence, claims, or EHR inputs?
What breaks if a study team needs end-to-end governance and reproducibility rather than standalone calculations?
When should RTI Health Solutions and L.E.K. Consulting be chosen for different evidence synthesis and modeling workflows?
How does ICON plc manage protocol-to-report integration for decision-analytic deliverables?
Which providers are better aligned to build budget impact logic from modeled cost drivers for reimbursement committees?
What technical requirements typically matter most for model inputs and schema alignment in health economics engagements?
How do Charles River Associates and Costello Medical differ in handling uncertainty for decision-maker review?
When is the transfer of model logic and audit-ready artifacts the deciding factor in onboarding and delivery?
Tools reviewed
Primary sources checked during evaluation.
Referenced in the comparison table and product reviews above.
- EconomicsTop 10 Best Behavioral Economics Services of 2026
- Science ResearchTop 10 Best Health Industries Research Services of 2026
- Digital Transformation In IndustryTop 10 Best Health Care Technology Services of 2026
- Healthcare MedicineTop 10 Best Health Services Software of 2026
- Data Science AnalyticsTop 10 Best Economics Software of 2026
Keep exploring
Comparing two specific tools?
Software Alternatives
See head-to-head software comparisons with feature breakdowns, pricing, and our recommendation for each use case.
Explore software alternatives→In this category
Economics alternatives
See side-by-side comparisons of economics tools and pick the right one for your stack.
Compare economics tools→